Publications – AM Pharma

Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury

24th October 2018/in Publications /by Info

View publication

Effects of a human recombinant alkaline phosphatase during impaired mitochondrial function in human renal proximal tubule epithelial cells

22nd December 2016/in Publications /by Info

View publication

Effects of a human recombinant alkaline phosphatase on renal hemodynamics, oxygenation and inflammation in two models of acute kidney injury

17th October 2016/in Publications /by Info

View publication

Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI)

27th September 2016/in Publications /by Info

View publication

Human recombinant alkaline phosphatase inhibits ex vivo platelet activation in humans

22nd September 2016/in Publications /by Info

View publication

Pharmacokinetic Modeling and Dose Selection in a Randomized, Double-Blind, Placebo-Controlled Trial of a Human Recombinant Alkaline Phosphatase in Healthy Volunteers

4th May 2016/in Publications /by Info

View publication

Biodistribution and translational pharmacokinetic modeling of a human recombinant alkaline phosphatase

29th August 2015/in Publications /by Info

View publication

Alkaline phosphatase protects against renal inflammation through dephosphorylation of lipopolysaccharide and adenosine triphosphate

29th July 2015/in Publications /by Info

View publication

Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl−/− mice by administration of soluble (non-targeted) chimeric alkaline phosphatase

26th November 2014/in Publications /by Info

View publication

Catalytic Signature of a Heat-Stable, Chimeric Human Alkaline Phosphatase with Therapeutic Potential

24th February 2014/in Publications /by Info

View publication